Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
12Bridge is a healthcare venture foundry focused on creating and advising early-stage companies in biomedical innovation. Public references describe it as a startup creation and incubation platform rather than a therapeutics developer with its own disclosed drug pipeline. The organization appears to be associated with founder Brenna Rauw and has been described as west coast-based in life sciences entrepreneurship materials. Available evidence suggests 12Bridge operates in venture formation, company building, and strategic support for health-related startups, rather than as a standalone biotech or pharma company with named clinical assets. Because public information is limited, many operating details such as programs, modalities, and partnerships are not clearly disclosed.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 12Bridge.